Regeneron's blockbuster eye drug posts weaker sales due to inventory impact
Go back to Regeneron's blockbuster eye drug posts weaker sales due to inventory impact| Regeneron (NASDAQ: REGN) | Delayed: 807.79 +9.62 (1.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $798.17 | 52 Week High | $592.36 | |||
| Open | $802.48 | 52 Week Low | $325.35 | |||
| Day High | $811.17 | P/E | 212.02 | |||
| Day Low | $791.31 | EPS | $3.81 | |||
| Volume | 270,966 | |||||

